serw-MX  [xml]  
 


    
 DeCS Categories

D27 Chemical Actions and Uses .
D27.505 Pharmacologic Actions .
D27.505.696 Physiological Effects of Drugs .
D27.505.696.477 Immunologic Factors .
D27.505.696.477.656 Immunosuppressive Agents .
D27.505.954 Therapeutic Uses .
D27.505.954.248 Antineoplastic Agents .
D27.505.954.248.384 Antineoplastic Agents, Immunological .
E02 Therapeutics .
E02.095 Biological Therapy .
E02.095.465 Immunomodulation .
E02.095.465.425 Immunotherapy .
E02.095.465.425.450 Immunosuppression .
E05 Investigative Techniques .
E05.478 Immunologic Techniques .
E05.478.610 Immunosuppression .
 
 Terms
 Synonyms & Historicals
Documents
LILACS e MDL
 
Antineoplastic Agents .
Anticancer Agents .
Antineoplastic Drugs .
Antineoplastics .
Antitumor Agents .
Antitumor Drugs .
Cancer Chemotherapy Agents .
Cancer Chemotherapy Drugs .
Chemotherapeutic Anticancer Agents .
Chemotherapeutic Anticancer Drug .
Agents, Anticancer .
Agents, Antineoplastic .
Agents, Antitumor .
Agents, Cancer Chemotherapy .
Agents, Chemotherapeutic Anticancer .
Chemotherapy Agents, Cancer .
Chemotherapy Drugs, Cancer .
Drug, Chemotherapeutic Anticancer .
Drugs, Antineoplastic .
Drugs, Antitumor .
Drugs, Cancer Chemotherapy .
Antineoplastic and Immunosuppressive Agents .
Antineoplastics, Immunosuppressives .
Substances that inhibit or prevent the proliferation of NEOPLASMS. .
1.00
 
Immunosuppression .
Anti-Rejection Therapy .
Therapy, Anti-Rejection .
Therapy, Antirejection .
Anti Rejection Therapy .
Anti-Rejection Therapies .
Antirejection Therapies .
Immunosuppressions .
Antirejection Therapy .
Deliberate prevention or diminution of the host's immune response. It may be nonspecific as in the administration of immunosuppressive agents (drugs or radiation) or by lymphocyte depletion or may be specific as in desensitization or the simultaneous administration of antigen and immunosuppressive drugs. .
0.68
 
Immunosuppressive Agents .
Immunosuppressants .
Agents, Immunosuppressive .
Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. .
0.68
 
Antineoplastic Agents, Immunological .
Antineoplastic MAbs .
Antineoplastics, Monoclonal Antibodies .
Antineoplastics, Monoclonal Antibody .
MAbs, Antineoplastic .
Monoclonal Antibodies, Antineoplastic .
Antibodies Antineoplastics, Monoclonal .
Antineoplastic Monoclonal Antibodies .
Immunological Antineoplastic Agents .
Monoclonal Antibodies Antineoplastics .
Monoclonal Antibody Antineoplastics .
Antineoplastic agents containing immunological agents (e.g. MAbs). These pharmacologic preparations inhibit or prevent the proliferation of NEOPLASMS. .
0.61